Eversept Partners, LP Opti Nose, Inc. Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$3.58 - $7.44 $17,921 - $37,244	-5,006 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$3.49 - $9.2 $349,000 - $919,999	-100,000 Reduced 95.23%	5,006 $22,000
Q4 2019 Nov 08, 2023	SELL	$6.27 - $11.41 $627 - $1,141	-100 Reduced 0.1%	105,006 $968,000
Q4 2019 Feb 13, 2020	SELL	$6.27 - $11.41 $627 - $1,141	-100 Reduced 0.1%	105,006 $968,000
Q2 2019 Nov 08, 2023	BUY	$6.4 - $10.94 $672,678 - $1.15 Million	105,106 New	105,106 $744,000
Q2 2019 Aug 13, 2019	BUY	$6.4 - $10.94 $672,678 - $1.15 Million	105,106 New	105,106 $744,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.